🔎 Trials Near Me

Akèy › Nefrit Lupus › Texas › Houston

Etid klinik pou Nefrit Lupus nan Houston, TX

8 etid pou Nefrit Lupus ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Ap rekriteFaz 2
  • Prolato Clinical Research Center, Houston
Laj 18 a 100 · Tout sèks · Mizajou Oct 1, 2026 · NCT05268289

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

Ap rekriteFaz 1
  • Baylor College of Medicine, Houston
Laj 18 a 60 · Tout sèks · Mizajou Sep 14, 2026 · NCT06975787

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

Ap rekriteFaz 2
  • Baylor College of Medicine Pediatric Immunology Allergy Rheumatology, Houston
Laj 8 a 20 · Tout sèks · Mizajou Sep 14, 2026 · NCT05538208

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Ap rekriteFaz 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Laj 18 a 65 · Tout sèks · Mizajou Aug 26, 2026 · NCT06121297

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

Ap rekriteFaz 4
  • Northwest Houston Arthritis Center, Houston
  • Novel Research LLC, Bellaire · 7 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Aug 3, 2026 · NCT07611214

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

Ap rekriteFaz 3
  • Novel Research, LLC., Houston
  • Northwest Houston Arthritis, Houston
  • Rheumatology Care Center, PLLC, Bellaire · 7 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Jul 30, 2026 · NCT07201129

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

Ap rekriteFaz 1/2
  • Nkarta Investigational Site, Houston
Laj 18 a 75 · Tout sèks · Mizajou Jun 4, 2026 · NCT06557265

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Ap rekriteFaz 1/2
  • MD Anderson Cancer Center, Houston
  • The University of Texas Health Science Center at Houston, Houston
Laj 18 ak plis · Tout sèks · Mizajou Apr 15, 2026 · NCT06434363

Etid Nefrit Lupus nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.